Individual Study / Vitger et al.; BMC Psychiatry. 2019;

The Momentum Trial: The Efficacy of Using a Smartphone Application to Promote Patient Activation and Support Shared Decision Making in People With a Diagnosis of Schizophrenia in Outpatient Treatment Settings: A Randomized Controlled Single-Blind Trial

The Momentum Trial: The Efficacy of Using a Smartphone Application to Promote Patient Activation and Support Shared Decision Making in People With a Diagnosis of Schizophrenia in Outpatient Treatment Settings: A Randomized Controlled Single-Blind Trial

Initiatives -
The aim of this trial is to investigate the effects of using a smartphone app to promote patient activation and support SDM for people with schizophrenia-spectrum disorders in an outpatient treatment setting. Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.
Start Year
2019
End Year
2020
Funding
Mental Health Services in the Capital Region, Denmark

Design

Study design
Clinical trial cohort

Marker Paper

Vitger T, Austin SF, Petersen L, Tønder ES, Nordentoft M, Korsbek L. The Momentum trial: the efficacy of using a smartphone application to promote patient activation and support shared decision making in people with a diagnosis of schizophrenia in outpatient treatment settings: a randomized controlled single-blind trial. BMC Psychiatry. 2019;19(1):185. Published 2019 Jun 17. doi:10.1186/s12888-019-2143-2

PUBMED 31208376

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
260
Number of participants with biosamples

Access

Availability of data and biosamples

Data
Biosamples
Other

Timeline

Population

A total sample size of 260 people with a diagnosis of schizophrenia, schizotypal or delusional disorder will be recruited from five OPUS teams (a specialized early intervention program) in Denmark between 2019 and 2020. The intervention will last for 6 months with data collection at baseline, and at 3 and 6 months.
Selection Criteria
Minimum age
18
Maximum age
35
Newborns
Twins
Countries
  • Denmark
Ethnic Origin
Health Status
  • A diagnosis of schizophrenia, schizotypal or delusional disorder
Other criteria
Exclusion Criteria: Do not understand or speak Danish Unable to give written informed consent to participate in the trial at the described terms Are participating in other research studies involving OPUS treatment and an app Do not have daily access to a smartphone Are suffering of mental retardation or dementia (F. 70-F.79, F.00-F.03)

Recruitment

Sources of recruitment
  • Clinical patients

Number of participants

Number of participants
260
Number of participants with biosamples
Data Collection Event
Participants will be placed in one of two groups: Intervention group: treatment as usual (TAU) together with the Momentum app or (2) Control group: TAU without the Momentum app.
Start Date
2019-01
End Date
2020-12
Data sources
  • Mobile data collection
    • Mobile phone
    • Smartphone apps